Paper36967432
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.
Wang J and 13 others. World J Surg Oncol, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients. Papers, record 36967432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36967432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Liver Transplantation | Major topic |
| Humans | |
| alpha-Fetoproteins | |
| Neoplasm Recurrence, Local | |
| Retrospective Studies | |
| Risk Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82273270 | National Natural Science Foundation of China | PubMed | ||
| 92159202 | National Natural Science Foundation of China | PubMed |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28989060 | Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. | Gastroenterology | 2018 | https://conductscience.org/library/papers/28989060 | PubMed |
| 2 | 33433946 | Cancer Statistics, 2021. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33433946 | PubMed |
| 3 | 11460231 | Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. | Liver Transpl | 2001 | https://conductscience.org/library/papers/11460231 | PubMed |
| 4 | 8594428 | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8594428 | PubMed |
| 5 | 27899297 | Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. | J Hepatol | 2017 | https://conductscience.org/library/papers/27899297 | PubMed |
| 6 | 32201284 | Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant. | J Hepatol | 2020 | https://conductscience.org/library/papers/32201284 | PubMed |
| 7 | 27169841 | Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America. | Liver Int | 2016 | https://conductscience.org/library/papers/27169841 | PubMed |
| 8 | 17563735 | Competing risk analysis using R: an easy guide for clinicians. | Bone Marrow Transplant | 2007 | https://conductscience.org/library/papers/17563735 | PubMed |
| 9 | 28295992 | Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis. | Liver Transpl | 2017 | https://conductscience.org/library/papers/28295992 | PubMed |
| 10 | 20062101 | Regression modeling of competing risk using R: an in depth guide for clinicians. | Bone Marrow Transplant | 2010 | https://conductscience.org/library/papers/20062101 | PubMed |
| 11 | 33021344 | Recent developments and ongoing trials in transplant oncology. | Liver Int | 2020 | https://conductscience.org/library/papers/33021344 | PubMed |
| 12 | 11391528 | Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. | Hepatology | 2001 | https://conductscience.org/library/papers/11391528 | PubMed |
| 13 | 25804634 | Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. | Gut | 2016 | https://conductscience.org/library/papers/25804634 | PubMed |
| 14 | 29307467 | Hepatocellular carcinoma. | Lancet | 2018 | https://conductscience.org/library/papers/29307467 | PubMed |
| 15 | 22750200 | Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22750200 | PubMed |
| 16 | 33031259 | Management and survival for patients with stage-I hepatocellular carcinoma: An observational study based on SEER database. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/33031259 | PubMed |
| 17 | 19058754 | Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19058754 | PubMed |
| 18 | 25777590 | Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation. | Hepatology | 2015 | https://conductscience.org/library/papers/25777590 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42008358 | SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42008358 | PubMed |
| 40709064 | Liver transplantation for HCC within and beyond Milan Criteria: single center experience with literature review. | Front Surg | 2025 | https://conductscience.org/library/papers/40709064 | PubMed |
| 40355422 | Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria. | Nat Commun | 2025 | https://conductscience.org/library/papers/40355422 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36967432
GET https://conductscience.org/api/papers/v1/36967432/authors